Drug Pricing News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–9 of 9 articles
$2M Gene Therapy Cures Need a Financing Model
Pharmalittle: Roche accuses U.S. of 'blackmail,' Supreme Court rules on skinny labels
FDA's New Stance on Drug Pricing: Impact on Approvals and Pharma Strategy
altRx GLP-1 Review 2026: FDA Updates on Semaglutide
BBSW AI Solution Debuts for Biotech Research in the US
Regeneron Announces Free Gene Therapy Otarmeni for Rare Hearing Loss in U.S. Government Agreement
ISPOR 2026: HEOR Policy & Pharma Pricing in Focus
SBC Medical Group Holdings Prices 3.1 Million Share Secondary Offering at Market Rate
FDA Approves Generic EpiPen: Key Details on Mylan’s Price Solution